Literature DB >> 16998652

Residual fatigue is independent of antecedent events and disease severity in Guillain-Barré syndrome.

M P J Garssen1, R Van Koningsveld, P A Van Doorn.   

Abstract

The occurrence of severe fatigue after Guillain-Barré syndrome (GBS), and its relation with disease course, clinical characteristics, and antecedent infections was studied in 100 GBS patients. Severe fatigue, expressed as a mean Fatigue Severity Scale (FSS) score of 5.0 or more, was present in 60% of all patients. It was more frequently present in females and in patients over 50 years (p < 0.01). There was no significant relationship between fatigue severity and the level of functional disability at nadir, antecedent events or infections, clinical variables, and time to follow-up after GBS.

Entities:  

Mesh：

Year:  2006        PMID： 16998652     DOI： 10.1007/s00415-006-0163-6

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


  9 in total

1.  Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome.

Authors:  R P Kleyweg; F G van der Meché; P I Schmitz
Journal:  Muscle Nerve       Date:  1991-11       Impact factor: 3.217

Review 2.  Guillain-Barré syndrome, CIDP and other chronic immune-mediated neuropathies.

Authors:  H P Hartung; F G van der Meché; J D Pollard
Journal:  Curr Opin Neurol       Date:  1998-10       Impact factor: 5.710

3.  Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands.

Authors:  R Van Koningsveld; P A Van Doorn; P I Schmitz; C W Ang; F G Van der Meché
Journal:  Neurology       Date:  2000-02-08       Impact factor: 9.910

4.  Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group.

Authors:  I S Merkies; P I Schmitz; J P Samijn; F G van der Meché; P A van Doorn
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

5.  Infections and course of disease in mild forms of Guillain-Barré syndrome.

Authors:  R Van Koningsveld; P I M Schmitz; C W Ang; J Groen; A D M E Osterhaus; F G A Van der Meché; P A Van Doorn
Journal:  Neurology       Date:  2002-02-26       Impact factor: 9.910

6.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.

Authors:  L B Krupp; N G LaRocca; J Muir-Nash; A D Steinberg
Journal:  Arch Neurol       Date:  1989-10

7.  Physical training and fatigue, fitness, and quality of life in Guillain-Barré syndrome and CIDP.

Authors:  M P J Garssen; J B J Bussmann; P I M Schmitz; A Zandbergen; T G Welter; I S J Merkies; H J Stam; P A van Doorn
Journal:  Neurology       Date:  2004-12-28       Impact factor: 9.910

8.  Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

Authors:  J D Fisk; P G Ritvo; L Ross; D A Haase; T J Marrie; W F Schlech
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

9.  Electrophysiological signs of permanent axonal loss in a follow-up study of patients with Guillain-Barré syndrome.

Authors:  Charlotte Dornonville de la Cour; Henning Andersen; Erik Stålberg; Anders Fuglsang-Frederiksen; Johannes Jakobsen
Journal:  Muscle Nerve       Date:  2005-01       Impact factor: 3.217
  9 in total
  8 in total

Review 1.  Neuropsychological/-psychiatric deficits in immune-mediated neuropathies.

Authors:  Andrew Chan; Ralf Gold
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

Review 2.  Fatigue in neuromuscular disorders: focus on Guillain-Barré syndrome and Pompe disease.

Authors:  J M de Vries; M L C Hagemans; J B J Bussmann; A T van der Ploeg; P A van Doorn
Journal:  Cell Mol Life Sci       Date:  2010-03       Impact factor: 9.261

3.  Fatigue, pain and muscle weakness are frequent after Guillain-Barré syndrome and poliomyelitis.

Authors:  Tiina Rekand; Arne Gramstad; Christian A Vedeler
Journal:  J Neurol       Date:  2009-03-06       Impact factor: 4.849

4.  Pulmonary Involvement in Patients with Guillain-Barré Syndrome in Subacute Phase.

Authors:  Meeka Khanna; Nidhi Rawat; Anupam Gupta; Madhu Nagappa; Arun B Taly; M R Rukmani; T N Sathyaprabha; Partha Haldar
Journal:  J Neurosci Rural Pract       Date:  2017 Jul-Sep

Review 5.  Diagnosis and management of Guillain-Barré syndrome in ten steps.

Authors:  Sonja E Leonhard; Melissa R Mandarakas; Francisco A A Gondim; Kathleen Bateman; Maria L B Ferreira; David R Cornblath; Pieter A van Doorn; Mario E Dourado; Richard A C Hughes; Badrul Islam; Susumu Kusunoki; Carlos A Pardo; Ricardo Reisin; James J Sejvar; Nortina Shahrizaila; Cristiane Soares; Thirugnanam Umapathi; Yuzhong Wang; Eppie M Yiu; Hugh J Willison; Bart C Jacobs
Journal:  Nat Rev Neurol       Date:  2019-09-20       Impact factor: 42.937

Review 6.  Psychiatric Sequelae of Guillain-Barré Syndrome: Towards a Multidisciplinary Team Approach.

Authors:  Christopher Hillyar; Anjan Nibber
Journal:  Cureus       Date:  2020-02-19

7.  Falls in people post-Guillain-Barré syndrome in the United Kingdom: A national cross-sectional survey of community based adults.

Authors:  Ian Davidson; Zachary J Parker
Journal:  Health Soc Care Community       Date:  2022-01-11

8.  Prevalence of fatigue in Guillain-Barre syndrome in neurological rehabilitation setting.

Authors:  Prajna Ranjani; Meeka Khanna; Anupam Gupta; Madhu Nagappa; Arun B Taly; Partha Haldar
Journal:  Ann Indian Acad Neurol       Date:  2014-07       Impact factor: 1.383
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.